WATSON DOUGLAS G 4/A
4/A · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 18, 2013
Insider Transaction Report
Form 4/AAmended
WATSON DOUGLAS G
Director
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,840→ 0 totalExercise: $11.64Exp: 2018-06-19→ Commmon Stock (8,840 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,538→ 0 totalExercise: $12.66Exp: 2020-06-17→ Commmon Stock (8,538 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−10,653→ 0 totalExercise: $9.95Exp: 2019-06-19→ Commmon Stock (10,653 underlying)
Footnotes (3)
- [F1]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,611 shares of Wright common stock at an exercise price of $22.32 per share.
- [F2]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,557 shares of Wright common stock at an exercise price of $19.08 per share.
- [F3]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,454 shares of Wright common stock at an exercise price of $24.27 per share.